{
    "hands_on_practices": [
        {
            "introduction": "Effective management of abortion complications begins with accurate diagnosis and risk assessment. In early pregnancy, distinguishing a viable intrauterine pregnancy from a potentially life-threatening ectopic pregnancy is a critical challenge. This exercise applies Bayes' theorem, the mathematical foundation of clinical reasoning, to quantify how our diagnostic certainty shifts as new evidence, such as laboratory values, imaging results, and patient symptoms, becomes available. By working through this scenario , you will develop a rigorous, quantitative approach to a common and high-stakes diagnostic dilemma.",
            "id": "4418326",
            "problem": "A clinician in an abortion care setting is evaluating an early gestation patient to prevent complications arising from an undiagnosed ectopic pregnancy. The patient has a positive pregnancy test, serum human chorionic gonadotropin (hCG) measured at $1500$ International Units per Liter, transvaginal ultrasound shows no intrauterine gestational sac, and she reports unilateral lower abdominal pain. Among patients presenting for abortion with a positive pregnancy test, the pre-test probability of ectopic pregnancy is $0.02$. For the finding of no intrauterine gestational sac on transvaginal ultrasound at serum hCG $1500$ International Units per Liter, the probability of this finding if the pregnancy is ectopic is $0.92$, and the probability of this finding if the pregnancy is an intrauterine gestation is $0.15$. For abdominal pain in early pregnancy, the probability of pain if the pregnancy is ectopic is $0.65$, and the probability of pain if the pregnancy is intrauterine is $0.30$. Assume that, conditional on the true location of the pregnancy, the ultrasound finding and pain are independent. Using Bayes’ theorem grounded in its definition and the odds–likelihood ratio form, update the probability of ectopic pregnancy given the combined evidence of no intrauterine sac and abdominal pain. Express your final answer as a decimal fraction and round to four significant figures.",
            "solution": "The problem requires the calculation of the posterior probability of an ectopic pregnancy given a set of clinical findings. This is a direct application of Bayes' theorem, which updates a prior belief based on new evidence. The problem is well-posed and scientifically grounded.\n\nFirst, let us define the relevant events and probabilities as provided in the problem statement.\nLet $E$ be the event that the pregnancy is ectopic.\nLet $I$ be the event that the pregnancy is intrauterine. As this is the only alternative to an ectopic pregnancy in this context, $I$ is the complement of $E$, i.e., $I = E^c$.\nLet $\\mathcal{S}$ be the event that a gestational sac is seen on ultrasound. The observed evidence is the absence of a sac, which we denote as $\\neg \\mathcal{S}$.\nLet $P$ be the event that the patient reports abdominal pain.\nLet $D$ represent the combined data or evidence, such that $D = \\neg \\mathcal{S} \\cap P$.\n\nThe given probabilities are:\nThe pre-test (prior) probability of ectopic pregnancy: $P(E) = 0.02$.\nThe prior probability of an intrauterine pregnancy is therefore: $P(I) = 1 - P(E) = 1 - 0.02 = 0.98$.\n\nThe conditional probabilities (likelihoods) for the ultrasound finding are:\nThe probability of no sac given an ectopic pregnancy: $P(\\neg \\mathcal{S} | E) = 0.92$.\nThe probability of no sac given an intrauterine pregnancy: $P(\\neg \\mathcal{S} | I) = 0.15$.\n\nThe conditional probabilities (likelihoods) for the symptom of pain are:\nThe probability of pain given an ectopic pregnancy: $P(P | E) = 0.65$.\nThe probability of pain given an intrauterine pregnancy: $P(P | I) = 0.30$.\n\nThe problem states that the ultrasound finding and the presence of pain are conditionally independent, given the location of the pregnancy. This assumption means:\n$P(\\neg \\mathcal{S} \\cap P | E) = P(\\neg \\mathcal{S} | E) \\times P(P | E)$\n$P(\\neg \\mathcal{S} \\cap P | I) = P(\\neg \\mathcal{S} | I) \\times P(P | I)$\n\nOur goal is to calculate the posterior probability of ectopic pregnancy given the combined evidence $D$, i.e., $P(E | D) = P(E | \\neg \\mathcal{S} \\cap P)$.\n\nThe problem requests the use of the odds-likelihood ratio form of Bayes' theorem. The relationship is given by:\n$$\n\\text{Posterior Odds} = \\text{Prior Odds} \\times \\text{Likelihood Ratio}\n$$\nIn terms of our variables, this is:\n$$\n\\frac{P(E | D)}{P(I | D)} = \\frac{P(E)}{P(I)} \\times \\frac{P(D | E)}{P(D | I)}\n$$\n\nFirst, we calculate the prior odds of an ectopic pregnancy:\n$$\n\\text{Odds}(E) = \\frac{P(E)}{P(I)} = \\frac{0.02}{0.98} = \\frac{2}{98} = \\frac{1}{49}\n$$\n\nNext, we calculate the likelihood ratio (LR) for the combined evidence $D$. The LR is the ratio of the probability of observing the evidence if the hypothesis is true to the probability of observing the evidence if the hypothesis is false.\n$$\n\\text{LR}(D) = \\frac{P(D | E)}{P(D | I)} = \\frac{P(\\neg \\mathcal{S} \\cap P | E)}{P(\\neg \\mathcal{S} \\cap P | I)}\n$$\nUsing the conditional independence assumption:\n$$\n\\text{LR}(D) = \\frac{P(\\neg \\mathcal{S} | E) \\times P(P | E)}{P(\\neg \\mathcal{S} | I) \\times P(P | I)}\n$$\nSubstituting the given values:\n$$\n\\text{LR}(D) = \\frac{0.92 \\times 0.65}{0.15 \\times 0.30} = \\frac{0.598}{0.045} = \\frac{598}{45}\n$$\n\nNow, we can calculate the posterior odds by multiplying the prior odds by the likelihood ratio:\n$$\n\\text{Odds}(E|D) = \\frac{P(E | D)}{P(I | D)} = \\text{Odds}(E) \\times \\text{LR}(D) = \\frac{1}{49} \\times \\frac{598}{45} = \\frac{598}{2205}\n$$\n\nFinally, we convert the posterior odds back to a probability. The relationship between probability $p$ and odds $o$ is $p = \\frac{o}{1+o}$.\n$$\nP(E | D) = \\frac{\\text{Odds}(E|D)}{1 + \\text{Odds}(E|D)} = \\frac{\\frac{598}{2205}}{1 + \\frac{598}{2205}} = \\frac{\\frac{598}{2205}}{\\frac{2205+598}{2205}} = \\frac{598}{2803}\n$$\n\nTo verify this using the standard form of Bayes' theorem, $P(E|D) = \\frac{P(D|E)P(E)}{P(D)}$:\nThe numerator is $P(D|E)P(E) = (0.92 \\times 0.65) \\times 0.02 = 0.598 \\times 0.02 = 0.01196$.\nThe denominator, $P(D)$, is found by the law of total probability:\n$P(D) = P(D|E)P(E) + P(D|I)P(I)$\n$P(D) = (0.92 \\times 0.65) \\times 0.02 + (0.15 \\times 0.30) \\times 0.98$\n$P(D) = 0.598 \\times 0.02 + 0.045 \\times 0.98 = 0.01196 + 0.0441 = 0.05606$.\nSo, $P(E|D) = \\frac{0.01196}{0.05606} = \\frac{1196}{5606} = \\frac{598}{2803}$.\nThe results from both methods are identical, confirming the calculation.\n\nNow, we compute the final numerical value and round to four significant figures as requested:\n$$\nP(E | D) = \\frac{598}{2803} \\approx 0.2133428469...\n$$\nRounding to four significant figures gives $0.2133$.\nThus, the updated probability of ectopic pregnancy given the ultrasound finding and the presence of abdominal pain is approximately $0.2133$.",
            "answer": "$$\\boxed{0.2133}$$"
        },
        {
            "introduction": "Hemorrhage is a leading cause of morbidity and mortality related to abortion, and its effective management hinges on timely intervention. Rather than relying on subjective estimation, modern safety protocols advocate for objective, physiology-based thresholds to trigger escalation of care. This problem  challenges you to integrate principles of circulatory physiology—such as estimated blood volume and hemodilution—to calculate a precise blood loss volume that should prompt intervention. Mastering this skill helps translate the clinical signs of compensated shock into a clear, actionable endpoint for initial management.",
            "id": "4418263",
            "problem": "A $32$-year-old patient at $12$ weeks of gestation undergoes suction evacuation for incomplete abortion. Pre-procedure hemoglobin is $9$ g/dL, and intraoperative vital signs indicate compensated shock (tachycardia with preserved systolic blood pressure), consistent with early hemorrhage. Assume the following well-tested clinical facts for adult nonpregnant females at this gestational age: estimated blood volume is approximated as $65$ mL/kg, and compensated shock corresponds to a Class II hemorrhage window beginning at a fractional blood loss of $0.15$ of estimated blood volume. Your institution’s protocol mandates immediate uterine intervention (re-aspiration or intrauterine balloon tamponade (UBT)) when cumulative blood loss first exceeds the earliest of:\n- the lower bound of Class II hemorrhage, i.e., a fractional loss of $0.15$ of estimated blood volume, or\n- the volume of blood loss that would reduce hemoglobin concentration from $9$ g/dL to $7$ g/dL under near-isovolemic replacement with isotonic crystalloid sufficient to maintain total intravascular volume approximately constant at the pre-bleed estimated blood volume.\n\nThe patient weighs $60$ kg. Using fundamental conservation of red cell mass and the above clinical definitions, compute the single earliest escalation threshold volume $V^{\\ast}$ to trigger uterine intervention. Round your final answer to three significant figures and express it in mL.",
            "solution": "The problem is valid as it is scientifically grounded in physiological principles, well-posed with sufficient data, and objective in its formulation. We can therefore proceed with a solution.\n\nThe objective is to determine the single earliest escalation threshold volume, $V^{\\ast}$, for uterine intervention. This threshold is defined as the minimum of two distinct calculated volumes, $V_1$ and $V_2$.\n\nThe givens from the problem statement are:\nPatient weight, $W = 60 \\text{ kg}$.\nEstimated blood volume (EBV) is $65 \\text{ mL/kg}$.\nInitial hemoglobin concentration, $Hb_i = 9 \\text{ g/dL}$.\nTarget final hemoglobin concentration, $Hb_f = 7 \\text{ g/dL}$.\nThe first threshold, $V_1$, corresponds to the lower bound of Class II hemorrhage, which is a fractional blood loss of $f_1 = 0.15$ of the EBV.\nThe second threshold, $V_2$, is the volume of blood loss that causes the hemoglobin to drop from $Hb_i$ to $Hb_f$ under conditions of isovolemic replacement with crystalloid.\n\nFirst, we calculate the patient's Estimated Blood Volume (EBV).\n$$ \\text{EBV} = W \\times (\\text{volume per kg}) $$\nSubstituting the given values:\n$$ \\text{EBV} = 60 \\text{ kg} \\times 65 \\frac{\\text{mL}}{\\text{kg}} = 3900 \\text{ mL} $$\n\nNext, we calculate the first threshold volume, $V_1$, based on the definition of the onset of Class II hemorrhage. This is defined as a loss of $15\\%$ of the EBV.\n$$ V_1 = f_1 \\times \\text{EBV} $$\nSubstituting the values:\n$$ V_1 = 0.15 \\times 3900 \\text{ mL} = 585 \\text{ mL} $$\n\nNow, we calculate the second threshold volume, $V_2$, based on the hemodilution model. The core principle is the conservation of total hemoglobin mass. Let the initial total blood volume be $V_i = \\text{EBV}$. The initial total mass of hemoglobin, $M_{Hb,i}$, is the product of the initial concentration $Hb_i$ and the initial volume $V_i$.\n$$ M_{Hb,i} = Hb_i \\times V_i $$\nWhen a volume of blood, $V_2$, is lost, the mass of hemoglobin lost is $M_{Hb,lost} = Hb_i \\times V_2$, because the lost blood has the initial hemoglobin concentration.\nThe remaining mass of hemoglobin in the circulation is:\n$$ M_{Hb,f} = M_{Hb,i} - M_{Hb,lost} = (Hb_i \\times V_i) - (Hb_i \\times V_2) = Hb_i \\times (V_i - V_2) $$\nThe problem states that there is near-isovolemic replacement with isotonic crystalloid, so the final total intravascular volume, $V_f$, is maintained approximately equal to the initial volume, $V_f \\approx V_i = \\text{EBV}$.\nThe final hemoglobin concentration, $Hb_f$, is the final mass of hemoglobin divided by the final volume:\n$$ Hb_f = \\frac{M_{Hb,f}}{V_f} = \\frac{Hb_i \\times (V_i - V_2)}{V_i} $$\nWe need to solve for the volume of blood lost, $V_2$.\n$$ \\frac{Hb_f}{Hb_i} = \\frac{V_i - V_2}{V_i} = 1 - \\frac{V_2}{V_i} $$\nRearranging the equation to solve for $V_2$:\n$$ \\frac{V_2}{V_i} = 1 - \\frac{Hb_f}{Hb_i} $$\n$$ V_2 = V_i \\times \\left(1 - \\frac{Hb_f}{Hb_i}\\right) $$\nSubstituting the given values, where $V_i = \\text{EBV} = 3900 \\text{ mL}$, $Hb_i = 9 \\text{ g/dL}$, and $Hb_f = 7 \\text{ g/dL}$:\n$$ V_2 = 3900 \\text{ mL} \\times \\left(1 - \\frac{7 \\text{ g/dL}}{9 \\text{ g/dL}}\\right) $$\n$$ V_2 = 3900 \\text{ mL} \\times \\left(\\frac{9-7}{9}\\right) $$\n$$ V_2 = 3900 \\text{ mL} \\times \\frac{2}{9} = \\frac{7800}{9} \\text{ mL} \\approx 866.67 \\text{ mL} $$\n\nThe escalation threshold $V^{\\ast}$ is the earliest of these two conditions, which corresponds to the minimum volume of blood loss.\n$$ V^{\\ast} = \\min(V_1, V_2) $$\n$$ V^{\\ast} = \\min(585 \\text{ mL}, 866.67 \\text{ mL}) $$\n$$ V^{\\ast} = 585 \\text{ mL} $$\nThe problem requires the answer to be rounded to three significant figures. The calculated value $585$ mL already has exactly three significant figures.\nThus, the single earliest escalation threshold volume to trigger uterine intervention is $585$ mL.",
            "answer": "$$\\boxed{585}$$"
        },
        {
            "introduction": "Preventing Rhesus (Rh) alloimmunization in Rh-negative patients is a fundamental aspect of comprehensive abortion care. While standard doses of anti-D immune globulin (RhIg) are commonly used, a deeper understanding of the underlying pathophysiology allows for more tailored care. This practice  guides you through a calculation of the appropriate RhIg dose based on first principles, linking it to the estimated fetal red blood cell volume, which varies with gestational age. This exercise reinforces the quantitative basis for our prophylactic strategies, moving beyond rote memorization to a nuanced application of fetal physiology.",
            "id": "4418388",
            "problem": "A Rhesus factor (Rh)-negative patient undergoes uterine evacuation at gestational age $8$ weeks and again at $16$ weeks in separate scenarios. To prevent alloimmunization, the patient should receive anti-D immune globulin (Rh immunoglobulin, RhIg). Assume the following well-tested physiological facts as a base:\n\n1. The volume of fetal whole blood scales approximately with fetal mass: if fetal mass is $m$ (in $\\text{kg}$), fetal whole blood volume is $V_{b} = b \\times m$, where $b$ is the fetal blood volume per unit mass. For this calculation, take $b = 100$ $\\text{mL}/\\text{kg}$.\n\n2. The combined fetal-placental whole blood volume can be approximated as a multiplicative factor of fetal whole blood volume: $V_{\\text{fp}} = \\lambda \\times V_{b}$. Use $\\lambda_{8} = 1.5$ at $8$ weeks and $\\lambda_{16} = 2.0$ at $16$ weeks to reflect the increasing placental contribution to the fetal circulation with gestational age.\n\n3. The fetal hematocrit (packed red blood cell fraction of whole blood) increases with gestational age; for this calculation, take $h_{8} = 0.30$ at $8$ weeks and $h_{16} = 0.50$ at $16$ weeks. The fetal red blood cell volume is therefore $V_{\\text{RBC}} = h \\times V_{\\text{fp}}$.\n\n4. Anti-D immune globulin neutralizes Rh-positive red blood cells such that a dose of $300$ $\\mu\\text{g}$ protects against $15$ $\\text{mL}$ of Rh-positive packed red blood cells, and a dose of $50$ $\\mu\\text{g}$ protects against $2.5$ $\\text{mL}$ of packed red blood cells. These facts imply a linear neutralization capacity per unit dose.\n\nAssume a conservative worst-case scenario for fetomaternal hemorrhage (FMH), in which the procedure could release up to the entire fetal-placental red blood cell volume ($V_{\\text{RBC}}$) into the maternal circulation. For each gestational age, compute the minimal RhIg dose required to neutralize $V_{\\text{RBC}}$ using the base facts above, and then identify the appropriate dose by rounding up to the nearest available vial size of either $50$ $\\mu\\text{g}$ or $300$ $\\mu\\text{g}$ to ensure coverage. Let the fetal mass be $m_{8} = 0.002$ $\\text{kg}$ at $8$ weeks and $m_{16} = 0.150$ $\\text{kg}$ at $16$ weeks. Express your final recommended doses in micrograms ($\\mu\\text{g}$), and round your answers to two significant figures. Provide both doses as a two-entry row vector corresponding to $8$ weeks and $16$ weeks, respectively.",
            "solution": "The problem is first validated to ensure it is scientifically grounded, well-posed, and objective.\n\n**Step 1: Extract Givens**\n- Patient: Rhesus factor (Rh)-negative.\n- Procedure: Uterine evacuation at gestational ages of $8$ weeks and at $16$ weeks.\n- Fetal whole blood volume: $V_{b} = b \\times m$, with $b = 100$ $\\text{mL}/\\text{kg}$.\n- Combined fetal-placental whole blood volume: $V_{\\text{fp}} = \\lambda \\times V_{b}$.\n- At $8$ weeks: $\\lambda_{8} = 1.5$.\n- At $16$ weeks: $\\lambda_{16} = 2.0$.\n- Fetal red blood cell (RBC) volume: $V_{\\text{RBC}} = h \\times V_{\\text{fp}}$.\n- Fetal hematocrit at $8$ weeks: $h_{8} = 0.30$.\n- Fetal hematocrit at $16$ weeks: $h_{16} = 0.50$.\n- Anti-D immune globulin (RhIg) neutralization capacity: A dose of $300$ $\\mu\\text{g}$ neutralizes $15$ $\\text{mL}$ of packed RBCs; a dose of $50$ $\\mu\\text{g}$ neutralizes $2.5$ $\\text{mL}$ of packed RBCs.\n- Assumption: Fetomaternal hemorrhage (FMH) volume equals the entire fetal-placental RBC volume, $V_{\\text{RBC}}$.\n- Fetal mass at $8$ weeks: $m_{8} = 0.002$ $\\text{kg}$.\n- Fetal mass at $16$ weeks: $m_{16} = 0.150$ $\\text{kg}$.\n- Task: For each gestational age, compute the minimal required RhIg dose, then round up to the nearest available vial size ($50$ $\\mu\\text{g}$ or $300$ $\\mu\\text{g}$), and report these final recommended doses with two significant figures as a two-entry row vector.\n\n**Step 2: Validate Using Extracted Givens**\n- **Scientific Grounding:** The problem is based on standard principles of obstetrics, specifically the management of Rh-negative pregnancies to prevent alloimmunization. The physiological values and relationships, while simplified, are representative approximations. The RhIg dosage and neutralization capacity ($300$ $\\mu\\text{g}$ for $15$ $\\text{mL}$ of RBCs) are standard clinical facts.\n- **Well-Posedness:** The problem provides all necessary equations, constants, and initial values to calculate a unique solution. The objective is clearly stated.\n- **Objectivity:** The problem is stated in precise, quantitative, and unbiased medical terms.\n- **Consistency:** The two data points for RhIg neutralization capacity are consistent, both yielding a neutralization constant of $20$ $\\mu\\text{g}$ of RhIg per $\\text{mL}$ of packed RBCs ($300/15 = 20$ and $50/2.5 = 20$).\n- **Completeness:** The problem is self-contained.\n\n**Step 3: Verdict and Action**\nThe problem is valid as it is scientifically sound, well-posed, objective, and self-consistent. A full solution will be provided.\n\nThe objective is to calculate the required dose of anti-D immune globulin (RhIg) for two scenarios: uterine evacuation at $8$ weeks and at $16$ weeks of gestation. The guiding principle is to neutralize the entire volume of fetal-placental red blood cells ($V_{\\text{RBC}}$) that could potentially enter the maternal circulation.\n\nFirst, we establish the neutralization constant, $K$, which is the dose of RhIg required per milliliter of packed fetal RBCs. The problem provides two consistent data points:\n$$\nK = \\frac{300 \\, \\mu\\text{g}}{15 \\, \\text{mL}} = 20 \\, \\mu\\text{g}/\\text{mL}\n$$\n$$\nK = \\frac{50 \\, \\mu\\text{g}}{2.5 \\, \\text{mL}} = 20 \\, \\mu\\text{g}/\\text{mL}\n$$\nThus, the neutralization constant is $K = 20 \\, \\mu\\text{g}/\\text{mL}$.\n\nThe minimal required dose, $D$, is the product of this constant and the volume of fetal RBCs to be neutralized, $V_{\\text{RBC}}$:\n$$\nD = K \\times V_{\\text{RBC}}\n$$\nThe volume of fetal RBCs is determined by a sequence of dependencies:\n$1$. Fetal whole blood volume: $V_{b} = b \\times m$\n$2$. Fetal-placental whole blood volume: $V_{\\text{fp}} = \\lambda \\times V_{b}$\n$3$. Fetal-placental RBC volume: $V_{\\text{RBC}} = h \\times V_{\\text{fp}}$\n\nCombining these expressions, we derive a general formula for $V_{\\text{RBC}}$ in terms of the primary parameters:\n$$\nV_{\\text{RBC}} = h \\times \\lambda \\times V_{b} = h \\times \\lambda \\times (b \\times m) = h \\lambda b m\n$$\nTherefore, the minimal required dose $D$ is:\n$$\nD = K h \\lambda b m\n$$\n\nWe now apply this formula to each scenario.\n\n**Scenario 1: Gestational Age of $8$ weeks**\nThe parameters are:\n- Fetal mass: $m_{8} = 0.002$ $\\text{kg}$\n- Blood volume constant: $b = 100$ $\\text{mL}/\\text{kg}$\n- Placental volume factor: $\\lambda_{8} = 1.5$\n- Fetal hematocrit: $h_{8} = 0.30$\n\nFirst, we calculate the worst-case volume of fetal RBCs, $V_{\\text{RBC}, 8}$:\n$$\nV_{\\text{RBC}, 8} = h_{8} \\lambda_{8} b m_{8} = (0.30) \\times (1.5) \\times (100 \\, \\text{mL}/\\text{kg}) \\times (0.002 \\, \\text{kg})\n$$\n$$\nV_{\\text{RBC}, 8} = 0.30 \\times 1.5 \\times 0.2 \\, \\text{mL} = 0.09 \\, \\text{mL}\n$$\nNext, we calculate the minimal required RhIg dose, $D_{8}$:\n$$\nD_{8} = K \\times V_{\\text{RBC}, 8} = (20 \\, \\mu\\text{g}/\\text{mL}) \\times (0.09 \\, \\text{mL}) = 1.8 \\, \\mu\\text{g}\n$$\nThe available RhIg vial sizes are $50$ $\\mu\\text{g}$ and $300$ $\\mu\\text{g}$. To ensure complete neutralization, we must round the required dose up to the nearest available vial size. The smallest available dose that covers $1.8$ $\\mu\\text{g}$ is the $50$ $\\mu\\text{g}$ vial.\nSo, the recommended dose for the $8$-week scenario is $50$ $\\mu\\text{g}$.\n\n**Scenario 2: Gestational Age of $16$ weeks**\nThe parameters are:\n- Fetal mass: $m_{16} = 0.150$ $\\text{kg}$\n- Blood volume constant: $b = 100$ $\\text{mL}/\\text{kg}$\n- Placental volume factor: $\\lambda_{16} = 2.0$\n- Fetal hematocrit: $h_{16} = 0.50$\n\nWe calculate the volume of fetal RBCs, $V_{\\text{RBC}, 16}$:\n$$\nV_{\\text{RBC}, 16} = h_{16} \\lambda_{16} b m_{16} = (0.50) \\times (2.0) \\times (100 \\, \\text{mL}/\\text{kg}) \\times (0.150 \\, \\text{kg})\n$$\n$$\nV_{\\text{RBC}, 16} = 0.50 \\times 2.0 \\times 15 \\, \\text{mL} = 1.0 \\times 15 \\, \\text{mL} = 15 \\, \\text{mL}\n$$\nNext, we calculate the minimal required RhIg dose, $D_{16}$:\n$$\nD_{16} = K \\times V_{\\text{RBC}, 16} = (20 \\, \\mu\\text{g}/\\text{mL}) \\times (15 \\, \\text{mL}) = 300 \\, \\mu\\text{g}\n$$\nThe calculated required dose of $300$ $\\mu\\text{g}$ exactly matches one of the available vial sizes. Therefore, the recommended dose for the $16$-week scenario is $300$ $\\mu\\text{g}$.\n\n**Final Answer Formulation**\nThe final recommended doses are $50$ $\\mu\\text{g}$ for the $8$-week scenario and $300$ $\\mu\\text{g}$ for the $16$-week scenario. The problem requires these answers to be rounded to two significant figures. To unambiguously represent this precision for integers ending in zero, we use scientific notation.\n- For the $8$-week dose: $50 \\, \\mu\\text{g} = 5.0 \\times 10^1 \\, \\mu\\text{g}$.\n- For the $16$-week dose: $300 \\, \\mu\\text{g} = 3.0 \\times 10^2 \\, \\mu\\text{g}$.\n\nThese two values are presented as a two-entry row vector, corresponding to $8$ weeks and $16$ weeks, respectively.",
            "answer": "$$\n\\boxed{\\begin{pmatrix} 5.0 \\times 10^{1} & 3.0 \\times 10^{2} \\end{pmatrix}}\n$$"
        }
    ]
}